Tab amoxilin 500 mg bd or tid
Reading File
Finding Sources
Short answer: TID (three times a day) is the standard regimen for amoxicillin 500 mg tablets in most adult infections.
Why:
- Pharmacodynamics: Amoxicillin is a beta-lactam, and beta-lactams are time-dependent killers - efficacy depends on the time the drug concentration stays above the MIC, not on peak concentration. Amoxicillin has a short half-life (~1-1.3 hours), so dosing every 8 hours (TID) maintains adequate blood/tissue levels between doses better than dosing every 12 hours (BD).
- Textbook/guideline support: Across the sources I checked - Goodman & Gilman's Pharmacological Basis of Therapeutics, Tintinalli's Emergency Medicine, and Creasy & Resnik's Maternal-Fetal Medicine - the standard adult regimen quoted is "amoxicillin 500 mg PO three times daily" for infections such as respiratory tract infections, otitis media/sinusitis, UTIs, and as an alternative regimen for syphilis in pregnancy - Creasy & Resnik's Maternal-Fetal Medicine.
- When BD dosing is used instead: Twice-daily dosing is generally paired with a higher tablet strength (e.g., amoxicillin 875 mg BD) to still deliver an adequate total daily dose (1750 mg/day) with fewer doses - this improves compliance for milder infections or step-down therapy. Plain 500 mg BD (total 1 g/day) under-doses many common indications compared with the standard 500 mg TID (1.5 g/day) or 875 mg BD (1.75 g/day) regimens, so it's not generally the preferred option unless specifically indicated (e.g., certain prophylaxis regimens or low-severity infections where a clinician has chosen a lower total dose).
Practical takeaway: If you're prescribing/administering plain 500 mg tablets for a standard infection (respiratory, skin, dental, UTI), TID is the conventional and guideline-supported frequency. BD dosing with 500 mg tablets would under-dose relative to standard regimens - if twice-daily dosing is desired for adherence reasons, the usual approach is to increase the strength to 875 mg BD rather than keep 500 mg BD.
If you can share the specific indication (e.g., dental infection, UTI, otitis media, H. pylori regimen), I can confirm the exact recommended frequency and duration for that condition.
How about moxclav 625 mg
Finding Sources
Moxclav 625 mg (amoxicillin 500 mg + clavulanic acid 125 mg) - standard frequency is TID (three times daily), not BD.
This is consistent across multiple sources I checked:
- Fishman's Pulmonary Diseases: "amoxicillin/clavulanate 500 mg/125 mg three times daily" (vs. 875 mg/125 mg or 2000 mg/125 mg dosed twice daily) - Fishman's Pulmonary Diseases and Disorders
- Goldman-Cecil Medicine: "amoxicillin/clavulanate (500 mg/125 mg three times daily or 875 mg/125 mg twice daily, or 2000 mg/125 mg twice daily)" - Goldman-Cecil Medicine
Why the strength matters here: co-amoxiclav dosing frequency is tied to the tablet strength, because the total daily amoxicillin dose needs to stay adequate while the clavulanate component is capped (excess clavulanate increases GI side effects, mainly diarrhea):
| Formulation | Frequency | Total daily amoxicillin |
|---|---|---|
| 500/125 mg (Moxclav 625) | TID | 1500 mg/day |
| 875/125 mg | BD | 1750 mg/day |
| 1000/125-200 mg (some markets) | BD | 2000 mg/day |
So with the 625 mg (500/125) strength specifically, twice-daily dosing would only deliver 1 g/day of amoxicillin - generally considered sub-therapeutic for most indications (respiratory tract infections, UTI, skin/soft tissue infections, sinusitis) where guidelines target 1.5-1.75 g/day of the amoxicillin component. That's why 625 mg formulations are conventionally labeled and prescribed as TID, while the higher-strength 875 mg or 1 g tablets are the ones used for BD regimens.
Practical takeaway: Moxclav 625 mg -> TID is correct and standard. If BD dosing is preferred for compliance, the appropriate product to switch to is the 1 g (875/125 mg or similar) strength, not keeping 625 mg at BD.
This is a shared conversation. Sign in to Orris to start your own chat.